ArticleMarine biotechnology (New York, N.Y.)2026
Exploring Marine Polysaccharides from Uroteuthis duvauceli Gladius Waste: Structural Insights and Biofunctional Properties.
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marine ecosystems represent a significant source of bioactive compounds, with cephalopods such as Uroteuthis duvauceli demonstrating considerable therapeutic potential. In this study, marine polysaccharides were extracted from the gladius of U. duvauceli and characterized using Fourier Transform Infrared Spectroscopy (FTIR), Field Emission Scanning Electron Microscopy (FESEM), and X-Ray Diffraction (XRD). The polysaccharide demonstrated notable antioxidant activity, including a DPPH scavenging effect of 45.17% at 10 mg/ml, superoxide radical scavenging activity of 64.19% at 10 mg/ml, and chelating ability of 71.59% at 10 mg/ml. Furthermore, the polysaccharide exhibited antibacterial activity against Escherichia coli (15 ± 1.53 mm) and Staphylococcus aureus (10 ± 0.58 mm), as determined by agar diffusion assays. Anticoagulant efficacy was assessed using Activated Partial Thromboplastin Time (APTT) and Prothrombin Time (PT) assays, yielding an APTT of 112 ± 3.52 s and a PT of 74 ± 2.25 s. These results indicate that U. duvauceli polysaccharides possess significant antibacterial, antioxidant, and anticoagulant properties, underscoring their potential as natural bioactive agents for pharmaceutical development. Further research is required to clarify their mechanisms of action and assess in vivo efficacy.
Indexed as
Identifiers
42154335What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.